These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17802961)

  • 21. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
    Pasqualoto KF; Ferreira EI; Santos-Filho OA; Hopfinger AJ
    J Med Chem; 2004 Jul; 47(15):3755-64. PubMed ID: 15239654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
    Dobrikov GM; Valcheva V; Nikolova Y; Ugrinova I; Pasheva E; Dimitrov V
    Eur J Med Chem; 2013 May; 63():468-73. PubMed ID: 23524112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
    De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
    J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
    Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
    Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
    Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
    Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antituberculosis activity of novel unfolded and macrocyclic derivatives of ent-kaurane steviol.
    Khaybullin RN; Strobykina IY; Dobrynin AB; Gubaydullin AT; Chestnova RV; Babaev VM; Kataev VE
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6909-13. PubMed ID: 23046964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A; Soltani F; Asadipour A
    Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
    Güzel O; Karali N; Salman A
    Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrahydro-2H-1,3,5-thiadiazine-5-(4-pyridylcarboxamide)-2-thione derivatives as prodrugs for isoniazid; synthesis, investigations and in vitro antituberculous activity.
    Aboul-Fadl T; Hassanin K
    Pharmazie; 1999 Apr; 54(4):244-7. PubMed ID: 10234734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antituberculosis agents, I: Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives.
    Foroumadi A; Mirzaei M; Shafiee A
    Pharmazie; 2001 Aug; 56(8):610-2. PubMed ID: 11534334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
    Tangallapally RP; Yendapally R; Lee RE; Hevener K; Jones VC; Lenaerts AJ; McNeil MR; Wang Y; Franzblau S; Lee RE
    J Med Chem; 2004 Oct; 47(21):5276-83. PubMed ID: 15456272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.